Beyond Air Faces Nasdaq Delisting Threat Over Sub-$1 Share Price, Plans Appeal
XAIR sits 21% above its 52-week low of $0.651.
Summary
Beyond Air, Inc. has received a notice from Nasdaq indicating its securities are subject to delisting due to failing to meet the $1.00 minimum bid price requirement for 30 consecutive business days. Critically, the company is not eligible for a standard compliance period due to a prior reverse stock split. This notice represents a significant negative development, particularly given the company's prior "going concern" warning issued in its Q3 2025 financial results. While Beyond Air intends to request a hearing, which will temporarily stay the delisting action, this event severely impacts investor confidence and the stock's liquidity. It overshadows recent positive news, such as the national group purchasing agreement announced on April 1st, and adds further pressure following a CEO transition on the same day. For a micro-cap company, a delisting threat can profoundly impair its ability to raise capital and maintain market visibility. Traders should closely monitor the outcome of the company's appeal to Nasdaq, as a final delisting could lead to a move to the OTC market, further restricting trading.
At the time of this announcement, XAIR was trading at $0.79 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.3M. The 52-week trading range was $0.65 to $5.84. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.